A significant difference in maximum blood glucose level was noted in patients with adverse outcomes (p= 0.0277) and patients with DM under continuous insulin infusion and normoglycemia did not have any difference in complications while patients with SIH had a severe prognosis. The gene discussed is INS; the disease is diabetes mellitus.